Effect of sorafenib on cisplatin-based radiochemotherapy in head and neck cancer cells

被引:0
|
作者
Moeckelmann, N. [1 ]
Kriegs, M. [2 ]
Rothkamm, K. [2 ]
Dikomey, E. [2 ]
Knecht, R. [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Lab Strahlenbiol & Expt Radioonkol, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
0214
引用
收藏
页码:106 / 106
页数:1
相关论文
共 50 条
  • [1] Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
    Moeckelmann, Nikolaus
    Rieckmann, Thorsten
    Busch, Chia-Jung
    Becker, Benjamin
    Gleissner, Lisa
    Hoffer, Konstantin
    Omniczynski, Maria
    Steinmeister, Leonhard
    Laban, Simon
    Grenman, Reidar
    Petersen, Cordula
    Rothkamm, Kai
    Dikomey, Ekkehard
    Knecht, Rainald
    Kriegs, Malte
    ONCOTARGET, 2016, 7 (17) : 23542 - 23551
  • [2] Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer
    Rades, Dirk
    Fehlauer, Fabian
    Sheikh-Sarraf, Mashid
    Kazic, Nadja
    Basic, Hiba
    Poorter, Robert
    Hakim, Samer G.
    Schild, Steven E.
    Dunst, Juergen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (02): : 235 - 241
  • [3] Cisplatin-based radiochemotherapy in elderly patients with cervical cancer
    Maricela, A. Rodice
    Minea, L.
    Bacinschi, X.
    Isacu, I.
    Tarlea, A.
    Nedelcu, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Carboplatin/paclitaxel-based radiochemotherapy is not inferior to cisplatin-based regimens in squamous cell carcinoma of head and neck (SCCHN)
    Maring, S.
    Elsayad, K.
    Ernst, I
    Haverkamp, U.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S89 - S89
  • [5] Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin-Based Treatments
    Marcu, Loredana G.
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [6] COMPARISON OF FOUR CISPLATIN-BASED RADIOCHEMOTHERAPY REGIMENS FOR NONMETASTATIC STAGE III/IV SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Rades, Dirk
    Kronemann, Stefanie
    Meyners, Thekla
    Bohlen, Guenther
    Tribius, Silke
    Kazic, Nadja
    Schroeder, Ursula
    Hakim, Samer G.
    Schild, Steven E.
    Dunst, Juergen
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1037 - 1044
  • [7] Simultaneous Radiochemotherapy with weekly Cisplatin for locally advanced Head and Neck Cancer
    Hipp, M.
    Mosorovic, S.
    Hautmann, M.
    Pohl, F.
    Koelbl, O.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 93 - 93
  • [8] Concurrent, cisplatin-based chemotherapy with accelerated radiotherapy for advanced head and neck cancer patients
    Skladowski, K. A., Sr.
    Rutkowski, T.
    Wygoda, A.
    Golen, M.
    Pilecki, B.
    Przeorek, W.
    Lukaszczyk-Widel, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck
    Pendleton, Kelsey P.
    Grandis, Jennifer R.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 103 - 116
  • [10] Radiochemotherapy in head and neck cancer
    Merlano, M
    Marchetti, G
    CANCER TREATMENT REVIEWS, 2003, 29 (04) : 291 - 296